Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers
Clinical trial NCT05353894 · UNKNOWN
Trial details
- NCT number
- NCT05353894
- Sponsor
- Genoscience Pharma
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-02
- Primary completion
- 2022-11-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.